According to MCKinsey report by 2010 more than 50000 professionals will be
required in the field clinical research India alone.
There is no doubt that the cost of doing clinical trials in the U.S. is absolutely
proohibilitive, and we can save substantially – I mean hundred of millions of
dollars of pure savings – by switching some of the trials to other , lower – cost
countries”
Glaxo Smithkline Former CEO Jean Pierre Garnier to Business Week
Over 100 pharmaceutical companies, including Fortune 100 companies
such as pfizer and Merck, are currently outsourcing clinical trials in INDIA,
India’s inherent advantage in IT skills helped in outsourcing of high end
activities like data management.. CYGNUS
Currently, most local and global CROs consider an operational presence in
India as key to their overall business plans, Farz kermani, ph. D., is a clinical
trials consultant at Bio Plan Associates, Inc
Basically, we would be glad to provide technical assistance to the Indian
government Andrew Von Eschenbach and US Health and Human Service
(HHS) Secretary Michael Leavitt.
India is turning out to be one of the hottest destinations for conducting global
clinical research, owning to a huge patient pool, easy recruitment of patients,
and high cost saving, Business Daily from THE HINDU group of publications.
A recent global study conducted by consulting firm AT Keaney says that India
is the second most preferred destination for outsourcing of clinical trials for
the pharma industry. THE ECONOMIC TIMES. |